neurology
Brain

Australian billionaire doubles his money backing neurologist’s drug hope


Re-purposing the diabetes drug exenatide for use in neurological conditions caused by raised intracranial pressure has delivered a multimillion dollar overnight windfall for mining billionaire Andrew ‘Twiggy’ Forrest. Forrest has a 9% stake in a startup pharma company Invex Therapeutics, which raised $12m at IPO last week as its 30m shares rose by 270% in ...

Already a member?

Enter your email to keep reading.


OR